Form 4 for TGTX TG THERAPEUTICS, INC.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-11 · accession 0001437749-25-028952 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-12 | 2025-09-11 | TGTX | Lonial Sagar | Dir | S - Sale | $32.24 | -20.9K | 94.1K | -18% | -$672.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | S | D | 20,852 | $32.24 | 94,061 | D | — | — | (F1) These shares were sold by the Company's restricted stock administrator in order to satisfy the Reporting Person's income tax obligations. (F2) Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $32.22 to $32.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Includes shares of restricted Common Stock, which vest over various time periods. |